30.01.2018 23:00:00

Cara Operations Limited to Release 2017 Fourth Quarter and Year End Results

VAUGHAN, ON, Jan. 30, 2018 /CNW/ - Cara Operations Limited (TSX: CARA.TO) will be releasing 2017 fourth quarter and year-end financial results on SEDAR (www.SEDAR.com) after the close of markets on Friday, March 9, 2018.

In conjunction with the news release, Cara has scheduled a conference call to discuss 2017 fourth quarter and year end results at 9:00 am Eastern Time on Monday, March 12, 2018.

To access the call, please call (647) 427-7450 or 1-888-231-8191, five to ten minutes prior to the start time. Conference ID 1890937. A telephone replay of the call will be available until midnight on April 12, 2018. To access the replay, please dial (416) 849-0833 or 1-855-859-2056 and enter passcode 1890937.

About CARA

Founded in 1883, Cara is Canada's oldest and largest full-service restaurant company. Cara franchises and/or operates some of the most recognized brands in the country including Swiss Chalet, Harvey's, St-Hubert, Milestones, Montana's, Kelsey's, East Side Mario's, New York Fries, Burger's Priest, Prime Pubs, Original Joe's, State & Main, Elephant & Castle, Bier Markt, Landing restaurants and Pickle Barrel. As at November 30, 2017, Cara had 1,259 restaurants, 1,204 of which were located in Canada and the remaining 55 locations were located internationally. 82% of Cara's total restaurants are operated by franchisees, 4% are operated as a joint venture and the remaining 14% are owned and operated corporately. Cara's shares trade on the Toronto Stock Exchange under the ticker symbol CARA.TO. More information about Cara is available at www.cara.com.

SOURCE Cara Operations Limited

Nachrichten zu Cara Therapeutics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cara Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cara Therapeutics Inc 0,23 0,97% Cara Therapeutics Inc